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Abstract 
A histone acetyltransferase Tat-interacting protein 60 kDa (Tip60) regulates the DNA damage response by 
acetylating histone and remodeling chromatin. In addition to histone acetyltransferase activity, Tip60 is known to 
regulate a variety of cellular functions, including gene expression, DNA damage response, cell migration and 
apoptosis. Lower expression of Tip60 is observed in lymphomas, melanomas, breast, colon, and lung cancer. It is 
widely accepted that Tip60 functions as a tumor suppressor. However, a role of Tip60 in gliomas still remains 
unclear. In this study, we investigated the role of Tip60 in the malignant behavior of human gliomas. By 
quantitative RT-PCR analysis using fresh human brain tumor tissues from 55 patients, we found that lower Tip60 
expression and higher membrane-type 1 matrix metalloproteinase (MT1-MMP) expression are associated with 
advanced tumor grade in glioma tissues. Knockdown of Tip60 in glioblastoma cells promoted cell adhesion, 
spreading and MT1-MMP transcription and thereby invasion, which was suppressed by inhibition of MT1-MMP 
and nuclear factor-kappa B (NF-κB) activity. We demonstrate for the first time that tumor suppressor Tip60 
down-regulates cell adhesion and MT1-MMP expression and thereby invasion of glioblastoma cells by 
suppressing NF-κB pathway. 
 
Abbreviations: ECM, extracellular matrix; HAT, histone acetyltransferase; HDAC, histone deacetylase; 
MT1-MMP, membrane-type 1 matrix metalloproteinase; NF-κB, nuclear factor-kappa B; PBS, 
phosphate-buffered saline; QRT-PCR, quantitative real-time-PCR; Tip60, Tat-interacting protein 60 kDa; 
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Tat-interacting protein 60 kDa (Tip60 also KAT5) is a member of the MOZ, Ybf2/Sas3, Sas2, and Tip60 
(MYST) family of histone acetyltransferase (HAT) and regulates the DNA damage response by acetylating 
histone and remodeling chromatin [1]. Besides HAT activity on chromatin remodeling, Tip60 possesses more 
divergent functions in many cellular processes. In transcriptional regulation, Tip60 can activate gene expression 
through its HAT activity, or act as a corepressor by the recruitment of histone deacetylase (HDAC) or through 
interactions with the transcriptional repressor. It plays crucial roles in cellular response to DNA damage by 
interacting with the kinase ataxia telangiectasia-mutated (ATM) and DNA-dependent protein kinase catalytic 
subunit (DNA-PKcs) [2]. Also, Tip60 is a major component of the p53 pathway. It acetylates a specific lysine 
residue in DNA-binding domain of p53 following DNA damage, resulting in the activation of a subset of target 
genes that trigger apoptosis [3, 4].  
Loss of Tip60 is associated with a growing number of cancer types [5]. Lower expression of Tip60 is 
observed in lymphomas, melanomas, breast, colon, and lung cancer [5,6]. Down-regulation of Tip60 gene 
expression in colorectal cancer is correlated with increasing tumor size, metastasis, and tumor stage [7]. Ectopic 
expression of Tip60 suppresses but its knockdown promotes melanoma migration [8]. Tip60 overexpression 
up-regulates gene expression of metastasis suppressor CD82 (KAI), resulting in the decrease of invasion in 
metastatic cancer cells [9]. The recent study has demonstrated that CD82 interferes with MT1-MMP-mediated 
MMP-2 activation by unknown mechanism [10].  
MT1-MMP, a first member of membrane-anchored MMP was originally identified as a tumor-specific 
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MMP-2 activator [11-13], and is now known to activate MMP-13 and degrade a wide range of extracellular 
matrix (ECM) components, including type I, II, III collagen, laminins, and fibronectin (FN) [13]. This enzyme 
also processes and interacts with membrane-tethered proteins such as integrins and CD44. Among MMPs, 
MT1-MMP is most closely associated with the invasive phenotype of human tumors. The inhibition of 
MT1-MMP suppresses tumor cell invasion both in vitro and in vivo. [13-15]. Thus, MT1-MMP is considered to 
play a significant role in tumor progression. 
To investigate the role of Tip60 in the malignant behavior of human gliomas, the expression level of Tip60 
was evaluated as a function of tumor grade in 55 surgical specimens. Our data indicate that lower expression of 
Tip60 is significantly associated with enhanced MT1-MMP expression and higher tumor grade. We also show 
that Tip60 knockdown facilitates cell attachment, spreading and transcription of MT1-MMP, and thereby 
promotes invasion of glioblastoma cells. Our findings provide insight into the molecular mechanism by which 






Cell culture and reagents  
 
Human glioblastoma U87 cells were maintained in Dulbecco’s modified Eagle’s medium supplemented with 
10% FBS. Glass coverslips and FN were purchased from Asahi Techno Glass (Tokyo, Japan). A synthetic MMP 
inhibitor BB94 was a kind gift from the Kotobuki Pharmaceutical (Nagano, Japan). An anti-MT1-MMP antibody 
(Clone 222-3E12) was gifted by Daiichi Fine Chemicals (Toyama, Japan). NF-κB inhibitor BAY11-7082, PI3-K 
inhibitor LY294002, ROCK inhibitor Y27632, and MLCK inhibitor Blebbistatin were purchased from Merck 
Millipore (Temecula, CA, USA). The immunological reagents used were; anti-CD44, anti-integrin β1, 
anti-integrin αv, anti-Tip60, and anti-p21
Cip antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA); 
anti-Tip60, anti-integrin β3, and anti-p53 antibodies (Merck Millipore); anti-N-cadherin and anti-paxillin 
antibodies (BD Biosciences, Bedford, MA, USA); an anti-tubulin antibody (Sigma-Aldrich, St Louis, MO, 
USA); DAPI, rhodamine-phalloidin, and Alexa Fluor-labeled secondary antibodies (Molecular Probes, Eugene, 
OR, USA).  
 
Clinical samples and histology  
 
Following informed consent, fresh human brain tumor tissues were obtained from 55 patients who underwent 
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therapeutic removal of gliomas at Kanazawa University Hospital as approved by the Institutional Review Board. 
Non-neoplastic control brain tissues were identified far from the tumor margins. The histoanalyses are based on 
the revised World Health Organization criteria [16]. The 55 gliomas consisted of 6 diffuse astrocytomas, 9 
anaplastic astrocytomas, and 40 glioblastomas. All of the tumor tissues were obtained at primary resection, and 
none of the patients had been subjected to chemotherapy or radiation therapy before resection. Tissue samples 
were obtained and immediately frozen in liquid nitrogen. Samples were maintained at −80°C until use. 
 
Quantitative real-time-PCR (QRT-PCR) 
  
Total RNA was isolated from fresh tumor tissues or cultured cells using the Sepasol-RNA I Super (Nacalai 
Tesque, Kyoto, Japan) according to the manufacture’s procedure. Reverse transcription of RNA was performed 
using the QuantiTect Reverse Transcription Kit (Quiagen, Valencia, CA, USA). Gene expression was quantified 
by QRT-PCR on a LightCycler using MasterPLUS SYBR Green (Roche Diagnostics, Penzberg, Germany) as 
described previously [17]. PCR was done with the following primers for tip60 (NM_182710): forward 
(5’-CAGGACAGCTCTGATGGAATAC) and reverse (5’-AGAGGACAGGCAATGTGGTGAG); mt1-mmp 
(NM_004995): forward (5’-GGAATAACCAAGTGATGGATGG) and reverse 
(5’-TTGTTTCCACGGAAGAAGTAGG); β-actin (NM_001101): forward 
(5’-CTACAATGAGCTGCGTGTGGC) and reverse (5’-CAGGTCCAGACGCAGGATGGC). 
Hs_GAPDH_1_SG QuantiTect Primer (Qiagen) was used to monitor the amplification of GAPDH gene 
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transcript as a control.  
 
siRNA-mediated protein knockdown 
  
The siRNA sequences were as follows: tip60, 5’-GUACGGCCGUAGUCUCAAGdTdT; tip60-2, 
5’-ACGGAAGGUGGAGGUGGUUdTdT [4]; mt1-mmp, 5’-GCGAUGAAGUCUUCACUUAdTdT. As a 
control, siRNA duplex with an irrelevant sequence was used (Qiagen). U87 cells were transfected with 20 nM of 
siRNA duplexes in Opti-MEM using Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA, USA) for 48 h and 





Cells were lyzed in 10 mM Tris-HCl (pH 7.5), 100 mM NaCl, 5 mM EDTA, 2 mM Na3VO4, 2 mM NaF, and 1% 
SDS after washing with phosphate-buffered saline (PBS). Protein concentration was determined using BCA 
assay (Pierce Thermo Scientific, Rockford, IL, USA). Cell lysates were separated by electrophoresis on 
SDS-polyacrylamide gels and transferred onto nitrocellulose membranes. Membranes were reacted with the 







Cells were seeded and cultured on glass coverslips. After washing with PBS, the cells were fixed with 4% 
paraformaldehyde, permeabilized with 0.5% Triton X-100, stained with the indicated antibodies and then 




The conditioned media were analyzed with an SDS-polyacrylamide gel containing 0.1% gelatin as described 
previously [12,14]. Gelatinolytic activity of MMP-2 was detected as unstained bands on a blue background. 
 
Cell attachment and spreading assay 
  
For cell attachment assay, cells in suspension were allowed to adhere to FN-coated 96-well plates in complete 
media for 6 h, and then stained with 1% crystal violet in methanol. After washing with PBS, the crystal violet 
was eluted with 10% acetic acid and measured by absorption at 560 nm. For cell spreading assay, cells were 




Cell invasion assay 
  
Cell invasion was assayed using modified Boyden chambers consisting of Transwell membrane filters (Corning 
Costar, Cambridge, MA, USA). Membranes were coated with 1mg/ml of Matrigel (BD Biosciences). U87 cells 
(2105 cells) were suspended in 0.5% FBS/DMEM containing 2 mg/ml bovine serum albumin and poured added 
to the upper chamber. Lower chambers were filled with 10% FBS/DMEM. After the cultivation incubation for 











Tip60 expression is down-regulated in glioblastoma tissues and cells 
 
To evaluate the potential role of Tip60 in the malignant behavior of human gliomas, the expression levels of 
Tip60 and MT1MMP were evaluated as a function of tumor grade in 55 surgical specimens. The mRNA levels of 
Tip60 and MT1-MMP in human normal brain and gliomas were evaluated by QRT-PCR using β-actin mRNA as 
the internal reference for normalization (Fig. 1a). QRT-PCR analysis demonstrated that Tip60 mRNA levels 
(Tip60 mRNA: β-actin mRNA ratios) were significantly lower in glioblastoma tissues (mean ± SD, 0.254 ± 
0.090; n = 40) than in normal brain tissues (0.799 ± 0.143; P < 0.001; n = 8), diffuse astrocytoma tissues (0.586 
± 0.193; P < 0.001; n = 6) and anaplastic astrocytoma (0.431 ± 0.122; P < 0.001; n = 9; Fig. 1a). In contrast, the 
expression levels of MT1-MMP were significantly higher as tumor grade increased. 
Furthermore, the expression levels of the Tip60 were lower in glioblastoma tissues obtained far from the 
necrosis of the tumors (0.25– to 0.52–fold) than those in normal brain tissues resected from the margins of the 
tumors in 5 cases of glioblastoma (Fig. 1b). The expression levels of MT1-MMP were higher in glioblastoma 
tissues than in normal brain tissues. These results indicated the reverse correlation between Tip60 and 
MT1-MMP mRNA expression level in glioblastomas.   
 




In order to study the pathological significance of Tip60 down-regulation in glioblastoma cell lines, U87 cells 
were transfected with either control siRNA or siRNA for Tip60. Tip60 knock-downed cell showed a flat and 
large cell size compared with mock-transfected cells (Fig. 2a: left panel). Immunoblot analysis revealed that 
Tip60 knockdown reduces p21Cip1 expression and stimulates the expression of integrin β3 and MT1-MMP (Fig. 
2b). The expression levels of p53, N-cadherin, integrin αv and β1 were not changed. The expression of 
MT1-MMP protein was up-regulated by 4.1-fold in Tip60 knock-downed cells compared with mock-transfected 
cells (Fig. 2c). The expression level of MT1-MMP mRNA was examined by real-time PCR quantification. Tip60 
knockdown up-regulated MT1-MMP mRNA expression by 3.3-fold compared with mock-transfected cells (Fig. 
2d). In parallel with the increase of MT1-MMP level, gelatin zymography analysis showed that Tip60 
knockdown promoted the activation of MMP-2 (Fig. 2ab), which was completely inhibited by 
double-knockdown with MT1-MMP (data not shown). MMP-2 expression levels were not significantly altered, 
and MMP-9 expression levels were not affected either as detected by gelatin zymography. These results show 
that Tip60 knockdown up-regulates MT1-MMP expression, resulting in the promotion of MMP-2 activation.  
The an integrin αvβ3 is known to contribute to cell attachment to vitronectin and FN. Concomitant with the 
increase of integrin β3 expression by Tip60 knockdown, cell adherence onto FN-coated plates was augmented 
(Fig. 2e). Immunofluorescence staining indicated that cell-ECM adhesions visualized by Paxillin staining and 
actin-stress fibers were well organized and formed in Tip60-silenced U87 cells when cells were plated onto 
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FN-coated coverslips (Fig. 2f). These results show that the increase of integrin β3 expression by Tip60 
knockdown promotes cell attachment and spreading. 
 
Tip60 knockdown promotes cell invasion 
 
ECM degradation is one of important steps in invasion of brain tumors, in which MT1-MMP plays a central role 
[18,19]. The effect of Tip60 knockdown on invasion into Matrigel was tested. In parallel with the enhancement 
of MT1-MMP-mediated MMP-2 activation by Tip60 knockdown, invasion of U87 cells into Matrigel was 
drastically enhanced (Fig. 3a). BB94 treatment interfered with invasion of Tip60-silenced cells, accompanying 
with the blockade of MMP-2 activation (Fig. 3b). These results indicated that Tip60 knockdown promotes 
invasion of U87 cells into Matrigel by up-regulating MT1-MMP expression.  
 
NFκ-B inhibition reduces invasion of Tip60-silenced cells  
 
To study the mechanism by which Tip60 knockdown up-regulates MT1-MMP expression, we tested the effect of 
a variety of reagents that were reported to suppress MT1-MMP expression, including PI3K inhibitor LY294002, 
ROCK inhibitor Y27632, Myosin II inhibitor Blebbistatin, and NFκ-B inhibitor BAY11-7082, on 
MT1-MMP-mediated MMP-2 activation in Tip60 knock-downed cells. Only BAY11-7082 significantly 
suppressed MMP-2 activation in Tip60 knock-downed U87 cells (Fig. 4a), which was accompanied with the 
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abrogation of MT1-MMP induction (Fig. 4bc). It also interfered with induction of integrin β3 and CD44, which 
are well known target genes of NFκ-B, in Tip60-silenced U87 cells. Thus, the enhanced invasive phenotype of 
Tip60 knock-downed U87 cell was impeded by BAY11-7082 treatment (Fig. 4d). These results suggest that 







The correlations between the reduced expression of Tip60 and tumor progression have been studied in many 
tumors. Recent studies have revealed that inactivation of Tip60 leads to defective DNA repair and increases 
cancer risk [20]. Overexpression of Tip60 up-regulates gene expression of metastasis suppressor CD82, resulting 
in decreased invasion of metastatic cancer cells into Matrigel [9]. In this study, we found that Tip60 expression 
level shows the reverse correlation with the tumor grade and MT1-MMP level in human glioma tissues (Fig. 1). 
Lower Tip60 expression may be associated with development and progression of gliomas.  
Present study demonstrated that Tip60 knockdown up-regulates integrin β3 expression, resulting in the 
enhancement of cell adhesion and spreading (Fig.2). Integrin αvβ3 is expressed on the most aggressive tumor 
cells in many cancers including high-grade glioma [21], and its expression correlates with metastasis by 
recruiting c-Src to integrin β3 [22]. Recent study has revealed that integrin β3 is necessary and sufficient to 
account for stemness and drug resistance by activating Ras/RalB/TBK1/NF-κB pathway [23,24]. Expression of 
integrin β3 is induced by a variety of factors, including hypoxia and inflammatory stress, and is down-regulated 
by HDAC inhibitor that activates HAT [25]. Tip60 functions not only as a co-activator but also as a co-repressor 
[1]. Tip60 may negatively regulate cellular adhesiveness at least in part through suppression of integrin β3 
expression, which may activate NF-κB pathway.  
MMP-2 activation has been correlated with invasive behavior of many tumors [13]. Knockdown of Tip60 
up-regulates the level of MT1-MMP mRNA and protein, resulting in the promotion of MMP-2 activation (Fig. 2). 
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Thus, Tip60 knockdown promoted U87 cell invasion into Matrigel, which was blocked by MMP inhibitor (Fig. 
3) and NF-κB inhibitor (Fig. 4). Consistent with our results, p38 MAPK-/NF-κB pathway up-regulates 
MT1-MMP expression [26,27]. Tip60 directly interacts and acetylates p53, and thus modulates its stability and 
transcriptional activity. Loss of p53 function results in the constitutive activation of NF-κB [28,29]. Knockdown 
of Tip60 down-regulates the expression of p21 which is a target gene of p53 (Fig. 2). Tip60 depletion may 
up-regulate NF-κB activity by down-regulating p53 activity (Fig. 4e). Alternatively, Tip60 negatively regulates 
the gene expression by binding to signal transducers and activators of transcription 3 [30], cAMP response 
element-binding protein [31], and zinc finger E box-binding protein [32] which are all involved in tumor 
progression. Regulation of transcriptional factors by Tip60 may be a therapeutic approach for inhibition of tumor 
progression. Further studies are required to examine the molecular mechanism by which Tip60 regulates NF-κB 
activity. 
NF-κB is activated, and its target genes are overexpressed in glioblastoma tissues. The higher NF-κB activity 
correlates with poor prognosis of glioblastoma patients [33]. We demonstrate here for the first time that tumor 
suppressor Tip60 negatively regulates cell adhesion and MT1-MMP expression in glioblastoma cells through 
NF-κB pathway, resulting in suppression of invasiveness. It is widely accepted that either HDAC inhibition or 
HAT activation suppresses cancer cell invasion. Treatment with HDAC inhibitors reduces the MMP-2 expression 
and/or induces the expression of MMP inhibitors such as tissue inhibitor of metalloproteinases and 
reversion-inducing cysteine-rich protein with Kazal motifs [34,35]. Tip60/NF-κB pathway may play a central 
role in regulation of invasiveness of gliomas. 
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In conclusion, our data indicate that Tip60 negatively regulates cell adhesion and MT1-MMP expression in 
glioblastoma cells through NF-κB pathway, which results in suppression of invasiveness. Tip60 may be a 
prognostic factor and a possible molecular target of gliomas.  
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Fig. 1 Tip60 and MT1-MMP mRNA expression in barin tumors. a Tip60 (left) and MT1-MMP (right) mRNA 
levels of 55 clinical samples were analyzed by Quantitative RT-PCR as described in “Methods”. NB, normal 
brain; LGA, low-grade astrocytomas; AA, anaplastic astrocytomas; GB, glioblastomas; *, p < 0.05; **, p < 0.01; 
***p < 0.001. b Tip60 (left) and MT1-MMP (right) mRNA levels of tumor and normal brain tissues resected 
from the margins of the tumors in 5 cases of glioblastoma were analyzed as described above.  
 
Fig. 2 Tip60 knockdown promotes cell attachment, spreading and MMP-2 activation. a U87 cells were 
transfected with control RNA (siScr) or Tip60 siRNA, and photos were taken at 48 h after replating. The cell 
lysates were analyzed by immunoblotting with anti-Tip60 or anti-tubulin antibody. The conditioned media was 
analyzed by gelatin zymography. b U87 cells were transfected with siRNA, and cell lysates were analyzed by 
immunoblotting with anti-Tip60, anti-p53, anti-p21Cip1, anti-integrin β3 (Intβ3), anti-integrin β1 (Intβ1), 
anti-integrin αv (Intαv), anti-N-cadherin (Ncad), anti-MT1-MMP (MT1), or anti-tubulin antibody. The 
conditioned media was analyzed by gelatin zymography. c MT1-MMP level was evaluated by densitometric 
analysis of the immunoblots. MT1-MMP levels are normalized to that of cells transfected with control RNA. 
The error bars are standard deviations of the mean values obtained from three independent experiments. *, p < 
0.05. d mRNA was extracted from U87 cells transfected with siRNA as above, and was subjected to Quantitative 
RT-PCR as described in “Methods”. The levels of mRNA were normalized to that of cells transfected with 
23 
 
control RNA. The error bars are standard deviations of the mean values obtained from three independent 
experiments. *, p < 0.05. e U87 cells transfected with siRNA were subjected to cell attachment assay to 
FN-coated culture plates as described in “Methods”. The error bars are standard deviations of the mean values 
obtained from three independent experiments. *, p < 0.05 (compared to the siScr). f Cells were also adhered on 
the FN-coated coverslips for 12 h and stained with DAPI, rhodamine-phalloidin and anti-paxillin antibody. Scale 
bars, 20 μm. 
 
Fig. 3 Tip60 knockdown promotes cell invasion. a U87 cells were transfected with siRNA for control or Tip60 
for 72 h and then seeded onto transwell chambers coated with Matrigel and cultured for 20 h with or without 
BB94. Cells on the filter underside (Lower panel) were counted as described in “Methods”. The error bars are 
standard deviations of the mean values obtained from three independent experiments. *, p < 0.001 (compared to 
the siScr). b Aliquots of conditioned media form upper chambers were analyzed by gelatin zymography. 
 
Fig. 4 Tip60 regulates glioblastoma cell invasion through NF-κB pathway. a U87 cells transfected with siRNA 
for Tip60 were detached, kept in suspension for 1 h, and seeded and cultured for 6h. Then, the cells were treated 
with MMP inhibitor BB94 (2 μM), PI3-K inhibitor LY294002 (25 μM), ROCK inhibitor Y27632 (10 μM), 
MLCK inhibitor Blebbistatin (10 μM), and NF-κB inhibitor BAY-11-7082 (7 μM) for 42 h. The conditioned 
media was analyzed by gelatin zymography. b U87 cells were transfected with siRNA for control or Tip60, and 
then treated with BAY-11-7082 for 42 h. The conditioned media was analyzed by gelatin zymography, and the 
24 
 
cell lysate were analyzed by immunoblotting with anti-MT1-MMP, anti-integrinβ3 or anti-tubulin antibody. c 
Quantitative RT-PCR for mRNA expression of MT1-MMP was performed as described in “Methods”. 
Expressions of these mRNA are normalized to that of cells transfected with control RNA. The error bars are 
standard deviations of the mean values obtained from three independent experiments. *, p < 0.05. d U87 cells 
were transfected with siRNA for Tip60 and then seeded onto transwell chambers coated with Matrigel and 
cultured for 20 h with or without BAY-11-7082 (5μM). Cells on the filter underside were counted. Columns, 
mean; bars, SD; *p < 0.001 (compared to the DMSO). e A model for invasion induced by Tip60 knockdown 
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